Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Messenger RNA of FUS gene" refers to the mRNA transcript produced from the FUS gene, which is translated to produce the RNA-binding protein FUS. The FUS protein is involved in multiple critical cellular processes, including regulation of transcription, alternative splicing, DNA damage repair, and transport of mRNA from the nucleus to the cytoplasm. Mutations in the FUS gene are associated with diseases such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and several cancer types due to altered protein function and aggregation[2][3][5]. However, the mRNA itself is not generally considered a direct therapeutic target like a receptor, enzyme, transporter, or transcription factor, but rather an intermediate molecule in gene expression. Thus, “Messenger RNA of FUS gene” is not itself a canonical therapeutic target, although recent experimental therapeutics may involve RNA targeting mechanisms such as antisense oligonucleotides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Messenger RNA of FUS gene.